Journal Article

Total Mortality Decreases as Cardiovascular Mortality Increases in All HIV Infected Adult Males and Only in Black Females

In a 2016 study researchers examined patterns of cardiovascular disease (CVD) mortality for HIV-infected adults between 1999-2013. Total and proportionate cardiovascular disease mortality in HIV-infected adults was compared to the general population and those with another chronic inflammatory condition, inflammatory polyarthroplasty. Total mortality in HIV-infected men and women decreased from 15,739 to 8660. CVD mortality significantly increased from 307 to 400 during the same period. This pattern was observed across all racial groups for HIV-infected men, but only non-Hispanic Black HIV-infected women experienced significantly higher CVD mortality. Proportionate cardiovascular disease mortality decreased in the general population and individuals with inflammatory polyarthropathy. HIV-infected subjects dying from CVD were more likely to be men, black, younger, urban-dwelling, and to have died in a medical facility compared to the general population. CVD mortality was greater among older individuals. Ischemic heart disease decreased in the general population, but a threefold increase in ischemic heart disease was observed for HIV-infected adults. Sensitivity analyses showed that CVD mortality in HIV-infected subjects was more likely due to hypertensive heart disease and pulmonary diseases (including pulmonary embolism and pulmonary hypertension).

By B. Caceres BA, BS, MS, NP and PhD Candidate is a Nurse Clinician and Adj. Instructor at the NYU Rory Meyers College of Nursing, NY, NY.

Purpose of this Program: The AAHIVM, ACRIA and AGS (collectively, the “Sponsors,” “we” or “us”) are sponsors of this Website and through it seek to address the unique needs and challenges that older adults of diverse populations living with HIV face as they age. However, the information in this Website is not meant to supplant the advice provided in a doctor-patient relationship.

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.



Phone: 202-659-0699
Fax: 202-659-0976


AAHIVM National Office
1627 Eye St NW Suite 835
Washington, D.C. 20006


The American Academy of HIV Medicine is a professional organization that supports the HIV practitioner and promotes accessible, quality care for all Americans living with HIV disease. Our membership of HIV practitioners and credentialed HIV Specialists™, HIV Experts™, and HIV Pharmacists™ provide direct care to the majority of HIV patients in the US.